215 related articles for article (PubMed ID: 24911473)
1. Best-kept secrets.
Nat Biotechnol; 2014 Jun; 32(6):499. PubMed ID: 24911473
[No Abstract] [Full Text] [Related]
2. Out in the open.
Nat Biotechnol; 2005 Feb; 23(2):153. PubMed ID: 15696130
[No Abstract] [Full Text] [Related]
3. Pharmaceuticals and medical devices: business practices.
Steiner DJ
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
[No Abstract] [Full Text] [Related]
4. Richard Gold.
Hoag H
Nat Biotechnol; 2009 May; 27(5):409. PubMed ID: 19430435
[No Abstract] [Full Text] [Related]
5. Protecting rights to early-stage technology.
Shuster MJ; Su H; Blaug S
Nat Biotechnol; 2003 Jun; 21(6):701-3. PubMed ID: 12776151
[No Abstract] [Full Text] [Related]
6. Putting your best mode forward.
Tsao YR; Tabtiang RK
Nat Biotechnol; 2000 Oct; 18(10):1113-4. PubMed ID: 11017054
[No Abstract] [Full Text] [Related]
7. Drug companies, doctors and disclosures.
Tuorto S; Chan MK; Adusumilli PS
Natl Med J India; 2004; 17(4):215-6. PubMed ID: 15372772
[No Abstract] [Full Text] [Related]
8. Patenting of human embryonic stem cells in Europe.
Treichel P
Biotechnol J; 2009 Apr; 4(4):462-4. PubMed ID: 19370720
[No Abstract] [Full Text] [Related]
9. The morality of biotech patents: differing legal obligations in Europe?
Ford R
Eur Intellect Prop Rev; 1997 Jun; 19(6):315-8. PubMed ID: 16538738
[No Abstract] [Full Text] [Related]
10. Conflicts brewing as phage display gets complex.
Glaser V
Nat Biotechnol; 1997 Jun; 15(6):506. PubMed ID: 9181564
[No Abstract] [Full Text] [Related]
11. Patents: patenting of stem cell related inventions in Europe.
Rutz B; Yeats S
Biotechnol J; 2006 Apr; 1(4):384-7. PubMed ID: 16892264
[No Abstract] [Full Text] [Related]
12. "Ganske" threatens biotechnology patents worldwide.
Glaser V
Nat Biotechnol; 1997 Feb; 15(2):121. PubMed ID: 9035128
[No Abstract] [Full Text] [Related]
13. Patent fight sparks biological warfare in the drug industry.
Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
[No Abstract] [Full Text] [Related]
14. Harmonization of biotechnological regulations in the European Community.
Sauer F
Bioprocess Technol; 1991; 13():455-68. PubMed ID: 1367146
[No Abstract] [Full Text] [Related]
15. Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape.
Lu DL; Kowalski TJ; Jarecki-Black J
Future Med Chem; 2010 Jan; 2(1):7-9. PubMed ID: 21426040
[No Abstract] [Full Text] [Related]
16. Robert Stoll. Interview by Charlotte Harrison.
Stoll R
Nat Rev Drug Discov; 2009 Dec; 8(12):926. PubMed ID: 19949397
[No Abstract] [Full Text] [Related]
17. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
Teitelbaum R; Cohen M
Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
[No Abstract] [Full Text] [Related]
18. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
Jones TM
Issue Brief Health Policy Track Serv; 2010 Jan; ():1-58. PubMed ID: 20213918
[No Abstract] [Full Text] [Related]
19. Are the new clinical trial transparency rules incompatible with the patentability requirements in Europe?
Kallenbach L; Vallazza MK
Nat Biotechnol; 2018 Oct; 36(10):928-930. PubMed ID: 30307932
[No Abstract] [Full Text] [Related]
20. Proposed changes to patent code loom over biotech industry.
Coombs A
Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
[No Abstract] [Full Text] [Related]
[Next] [New Search]
